Cargando…

National Mass Drug Administration Costs for Lymphatic Filariasis Elimination

BACKGROUND: Because lymphatic filariasis (LF) elimination efforts are hampered by a dearth of economic information about the cost of mass drug administration (MDA) programs (using either albendazole with diethylcarbamazine [DEC] or albendazole with ivermectin), a multicenter study was undertaken to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldman, Ann S., Guisinger, Victoria H., Aikins, Moses, Amarillo, Maria Lourdes E., Belizario, Vicente Y., Garshong, Bertha, Gyapong, John, Kabali, Conrad, Kamal, Hussein A., Kanjilal, Sanjat, Kyelem, Dominique, Lizardo, Jefrey, Malecela, Mwele, Mubyazi, Godfrey, Nitièma, P. Abdoulaye, Ramzy, Reda M. R., Streit, Thomas G., Wallace, Aaron, Brady, Molly A., Rheingans, Richard, Ottesen, Eric A., Haddix, Anne C.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041814/ https://www.ncbi.nlm.nih.gov/pubmed/17989784 http://dx.doi.org/10.1371/journal.pntd.0000067

Ejemplares similares

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana
por: Biritwum, Nana-Kwadwo, et al.
Publicado: (2017)

Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes
por: Michael, Edwin, et al.
Publicado: (2008)

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti
por: Rheingans, Richard D, et al.
Publicado: (2004)

The role of community participation for sustainable integrated neglected tropical diseases and water, sanitation and hygiene intervention programs: A pilot project in Tanzania
por: Madon, Shirin, et al.
Publicado: (2018)

Two decades of public health achievements in lymphatic filariasis (2000–2020): reflections, progress and future challenges
por: Malecela, Mwelecele, et al.
Publicado: (2020)

Treatment choices for fevers in children under-five years in a rural Ghanaian district
por: Nonvignon, Justice, et al.
Publicado: (2010)

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission
por: Simonsen, Paul E, et al.
Publicado: (2013)

Biosocial Determinants of Persistent Schistosomiasis among Schoolchildren in Tanzania despite Repeated Treatment
por: Donohue, Rose E., et al.
Publicado: (2017)

How lymphatic filariasis was eliminated from an urban poor setting in Santo Domingo, Dominican Republic
por: Gonzales, Manuel, et al.
Publicado: (2019)

Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
por: Amarillo, Maria Lourdes E, et al.
Publicado: (2008)

Data reporting constraints for the lymphatic filariasis mass drug administration activities in two districts in Ghana: A qualitative study
por: da-Costa Vroom, Frances Baaba, et al.
Publicado: (2015)

Neglected Tropical Diseases and the Millennium Development Goals-why the "other diseases" matter: reality versus rhetoric
por: Molyneux, David H, et al.
Publicado: (2011)

147. Defining the Optimal Serial Testing Interval and Features for Identifying Patients with Early SARS-CoV-2 Infection
por: Kanjilal, Sanjat
Publicado: (2021)

Lymphatic filariasis patient identification in a large urban area of Tanzania: An application of a community-led mHealth system
por: Mwingira, Upendo, et al.
Publicado: (2017)

A Multicenter Evaluation of Diagnostic Tools to Define Endpoints for Programs to Eliminate Bancroftian Filariasis
por: Gass, Katherine, et al.
Publicado: (2012)

Elimination of lymphatic filariasis: current perspectives on mass drug administration
por: Gyapong, John O, et al.
Publicado: (2018)

A Tale of Trial and Triumph: Molecular Diagnostics for Severe Acute Respiratory Coronavirus 2 Over the First Two Years of the Coronavirus Disease 2019 Pandemic
por: Kanjilal, Sanjat, et al.
Publicado: (2022)

Covid-19 Molecular Testing and Clinical Correlates
por: Kanjilal, Sanjat, et al.
Publicado: (2022)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Urban lymphatic filariasis in the metropolis of Dar es Salaam, Tanzania
por: Mwakitalu, Mbutolwe E, et al.
Publicado: (2013)

Something old or something new? Social health insurance in Ghana
por: Witter, Sophie, et al.
Publicado: (2009)

Progress towards elimination of lymphatic filariasis in the Eastern Mediterranean Region
por: Ramzy, Reda M R, et al.
Publicado: (2020)

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
por: Krentel, Alison, et al.
Publicado: (2020)

A mathematical model of the dynamics of lymphatic filariasis in Caraga Region, the Philippines
por: Salonga, Pamela Kim N., et al.
Publicado: (2021)

301. Penicillin Versus Cefazolin or Anti-staphylococcal Penicillins for Penicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aldhaeefi, Mohammed, et al.
Publicado: (2020)

An exploratory study of the policy process and early implementation of the free NHIS coverage for pregnant women in Ghana
por: Witter, Sophie, et al.
Publicado: (2013)

Elimination of lymphatic filariasis as a public health problem from the Cook Islands
por: Ave, Charlie, et al.
Publicado: (2018)

How to (or Not to) Integrate Vertical Programmes for the Control of Major Neglected Tropical Diseases in Sub-Saharan Africa
por: Kabatereine, Narcis B., et al.
Publicado: (2010)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 Years
por: Ottesen, Eric A., et al.
Publicado: (2008)

Setting the stage for a Global Programme to Eliminate Lymphatic Filariasis: the first 125 years (1875–2000)
por: Ottesen, Eric A, et al.
Publicado: (2020)

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
por: Simonsen, Paul E., et al.
Publicado: (2010)

Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease
por: Ramaiah, K. D., et al.
Publicado: (2014)

A case for South-South collaboration for trachoma elimination
por: Malecela, Mwele, et al.
Publicado: (2016)

Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success
por: Ichimori, Kazuyo, et al.
Publicado: (2014)

1548. Risk of Severe Herpes Zoster (HZ) in Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients
por: Baumrin, Emily, et al.
Publicado: (2018)

Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19
por: Shappell, Claire N., et al.
Publicado: (2022)

Factors Influencing Drug Uptake during Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania
por: Kisoka, William J., et al.
Publicado: (2014)

African regional progress and status of the programme to eliminate lymphatic filariasis: 2000–2020
por: Deribe, Kebede, et al.
Publicado: (2020)

Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
por: Simonsen, Paul E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7vonu10iacu863l70nvocve2ts